Logo

Molecular Iodine as a New Frontline Defense Against COVID19

Room type

Permanent

This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
This field is required. Double-check the spelling.
Required fields
If you have already registered and can't locate your registration confirmation email,click here!
The email address is incorrect. Please double-check your email address.

A confirmation email with logging details has been sent to the provided email.

System configuration test. Click here!

Agenda

TITLE:

Molecular Iodine: A New Frontline Defense Against COVID19. An Analysis of Anti-microbial Technologies in Dental Practices to Advance Safety and Efficacy During a Pandemic

"There is overwhelming evidence backed by research that the COVID-19 virus can be safely and effectively inactivated by molecular iodine, the biocidal component of povidone-iodine." D. Scott Trettenero, DDS. November 16, 2020 DentistryIQ

*Instructions for this On Demand Webinar. Please download (7) handouts (below). Upon completion of this webinar, and upon logging out - You will receive an email with link to the continuing education evaluation. (Check your spam). Likewise at the end of the webinar, a button will appear at the top of the screen to link you with the evaluation. Complete the brief evaluation, and your CE verification will be sent to your email. Should you have an email other than Gmail, be sure to check your spam folder. If you have any concerns you may reach us: email support@dentalcenow.com, chat with us on our website www.dentalceacademy.com  (9 - 4 p.m. PST) :  Mon - Fri), or call/text 888-964-3976 (9 - 4 p.m. PST: Mon - Fri). We appreciate your attendance, and will help you with your concerns or questions. For product support concerning ioTech International, reach out directly: herbmoskowitz@iotechinternational.com or visit their website: www.ioTechInternational.com

COST: No charge

1 CEU: Recorded. AGD PACE. Recorded August 11, 2020

AGD PACE Subject Code: 010 Basic Sciences.

Pharmacotherapeutics, Emerging Technologies

SPONSOR: ioTech International

SPEAKER: Dr. Herb Moskowitz

FOR Live Q & A with Dr. Moskowitz, register for the next upcoming live presentation here: https://www.dentalceacademy.com/herb-moskowitz

DESCRIPTION: A new generation of super-iodines is being developed with proven anti-virucidal activity against SARS-CoV-2. This course will analyze the efficacy and safety of current anti-microbial rinses and introduce the latest generation of rinses under development. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses to protect both patients and staff. Hint: If you are currently using hydrogen peroxide or chlorhexidine gluconate as a pre-procedural rinse, you will be surprised by the results of these studies.

‚Äč

LEARNING OBJECTIVES:

  1. Review the evolution of iodine in becoming a standard of care.
  2. Learn about a technological breakthrough leading to a new class of "super" iodines.
  3. Compare the efficacy of commonly used oral rinses against SARS-CoV-2.
  4. Understand how the implementation of the new "super" iodines in your practice will benefit your patients.
  5. Compare the advantages and disadvantages of commonly used oral rinses.
  6. Describe the misconceptions related to iodine sensitivity.
  7. Learn why periodontal bacteremias are now considered a cause of cardiovascular disease.

  

DENTAL CE ACADEMY DISCLAIMER:

The views expressed and opinions and materials presented during these presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speakers' own clinical experience and should not be construed as Dental CE Academy recommended. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in the fields of dentistry. Dental CE Academy appreciates its members who share their knowledge. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding.

DISCLOSURE OF SPEAKER AND FACULTY COMMERCIAL RELATIONSHIPS

According to Dental CE Academy's  Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.

CONFLICT OF INTEREST/DISCLOSURE:

Dr. Moskowitz is the Chairman of ioTech International, is not a paid sponsor or speaker of Dental CE Academy.   Dr. Moskowitz is financially affiliated with ioTech International.

Dental CE Academy has no financial interest or association with ioTech International or any of the companies beyond hosting services.

Presenter

Dr. Herb Moskowitz

Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech's U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.
DENTAL CE ACADEMY DISCLAIMER:
The views expressed and opinions and materials presented during these presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speakers' own clinical experience and should not be construed as Dental CE Academy recommended. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to new interest and scientific breakthroughs in dentistry.